Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF Overview

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF Operating Income

Operating Income for XDNA.

Quarterly Operating Income

N/A

Annual Operating Income (TTM)

N/A

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin